Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari Syndrome

Background & Aims: Budd–Chiari Syndrome (BCS) results from obstruction to hepatic venous outflow, with myeloproliferative disorder (MPD) accounting for up to 40% of cases. A number of BCS cases labelled as “idiopathic” do not fulfill the diagnostic criteria for MPD but have features suggestive o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2006-06, Vol.130 (7), p.2031-2038
Hauptverfasser:	Patel, Raj K., Lea, Nicholas C., Heneghan, Michael A., Westwood, Nigel B., Milojkovic, Dragana, Thanigaikumar, Murugaiyan, Yallop, Deborah, Arya, Roopen, Pagliuca, Antonio, Gäken, Joop, Wendon, Julia, Heaton, Nigel D., Mufti, Ghulam J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Alleles Base Sequence Budd-Chiari Syndrome - epidemiology Budd-Chiari Syndrome - genetics Budd-Chiari Syndrome - physiopathology Cohort Studies Disease Progression Female Gene Expression Regulation Genetic Markers Humans Janus Kinase 2 Male Middle Aged Molecular Sequence Data Mutation, Missense Polymerase Chain Reaction Probability Prognosis Protein-Tyrosine Kinases - genetics Protein-Tyrosine Kinases - metabolism Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Retrospective Studies Sensitivity and Specificity Statistics, Nonparametric
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!